← Evidence map

ArticleiScience2021

Targeting CD38-dependent NAD

Bo Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

47 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it

The trial

NCT06567717phase 260 enrolled2025
Full record →Abstract, authors, funding and every citing paper · PMID 33385109